Deflexifol (a novel formulation of 5FU): Pharmacokinetics in a phase 1 trial in comparison to 5FU.

Citation

• Ackland, S. P., Garg, M. B., Ranson, M., Jokela, R., Brungs, D., Aghmesheh, M., . . . Clingan, P. R. (2017). Deflexifol (a novel formulation of 5FU): Pharmacokinetics in a phase 1 trial in comparison to 5FU.. Journal of Clinical Oncology, 35(15_suppl), 2530. doi:10.1200/jco.2017.35.15_suppl.2530

Digital Object Identifier (doi)

• 10.1200/jco.2017.35.15_suppl.2530

Web Of Science Accession Number

Start Page

• 2530

End Page

• 2530

Volume

• 35

Issue

• 15_suppl

Abstract

UOW Authors

•   Aghmesheh, Morteza (external author)
•   Brungs, Daniel
•   Clingan, Phillip (external author)
•   De Souza, Paul (external author)
•   Ranson, Marie

Publication Date

• 2017

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• Ackland, S. P., Garg, M. B., Ranson, M., Jokela, R., Brungs, D., Aghmesheh, M., . . . Clingan, P. R. (2017). Deflexifol (a novel formulation of 5FU): Pharmacokinetics in a phase 1 trial in comparison to 5FU.. Journal of Clinical Oncology, 35(15_suppl), 2530. doi:10.1200/jco.2017.35.15_suppl.2530

Digital Object Identifier (doi)

• 10.1200/jco.2017.35.15_suppl.2530

Web Of Science Accession Number

Start Page

• 2530

End Page

• 2530

Volume

• 35

Issue

• 15_suppl